Cargando…

High expression of angiogenic factor AGGF1 is an independent prognostic factor for hepatocellular carcinoma

BACKGROUND: Angiogenesis plays a critical role in tumor growth and metastasis. Angiogenic factor with G patch and FHA domains 1 (AGGF1) has been recently identified as a novel initiator of angiogenesis. However, the function and the prognostic values of AGGF1 in hepatocellular carcinoma remain poorl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tu, Jianfei, Ying, Xihui, Zhang, Dengke, Weng, Qiaoyou, Mao, Weibo, Chen, Li, Wu, Xulu, Tu, Chaoyong, Ji, Jiansong, Huang, Yuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762347/ https://www.ncbi.nlm.nih.gov/pubmed/29340079 http://dx.doi.org/10.18632/oncotarget.22880

Ejemplares similares

Angiogenic Factor AGGF1 Promotes Therapeutic Angiogenesis in a Mouse Limb Ischemia Model
por: Lu, Qiulun, et al.
Publicado: (2012)

miR-590-5p suppresses hepatocellular carcinoma chemoresistance by targeting YAP1 expression
por: Chen, Minjiang, et al.
Publicado: (2018)

Protein therapy of skeletal muscle atrophy and mechanism by angiogenic factor AGGF1
por: He, Zuhan, et al.
Publicado: (2023)

CPEB1 mediates hepatocellular carcinoma cancer stemness and chemoresistance
por: Xu, Min, et al.
Publicado: (2018)

Angiogenic Factor AGGF1 Activates Autophagy with an Essential Role in Therapeutic Angiogenesis for Heart Disease
por: Lu, Qiulun, et al.
Publicado: (2016)

Radiofrequency Ablation (RFA) Combined with Transcatheter Arterial Chemoembolization (TACE) for Patients with Medium-to-Large Hepatocellular Carcinoma: A Retrospective Analysis of Long-Term Outcome
por: Liu, Weiwen, et al.
Publicado: (2020)

Identification and validation of the angiogenic genes for constructing diagnostic, prognostic, and recurrence models for hepatocellular carcinoma
por: Zhu, Jinyu, et al.
Publicado: (2020)

Angiogenic Factor with G Patch and FHA Domains 1 (AGGF1) Acts as Diagnostic Biomarker and Adverse Prognostic Factor of Hepatocellular Carcinoma (HCC): Evidence from Bioinformatic Analysis
por: Wang, Wensheng, et al.
Publicado: (2020)

Angiogenic Factor with G-patch and FHA Domain 1 (AGGF1) Expression in Human Vascular Lesions
por: Zhan, Maosheng, et al.
Publicado: (2016)

A Radiomics Signature-Based Nomogram to Predict the Progression-Free Survival of Patients With Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization Plus Radiofrequency Ablation
por: Fang, Shiji, et al.
Publicado: (2021)

ZFP36 Binds With PRC1 to Inhibit Tumor Growth and Increase 5-Fu Chemosensitivity of Hepatocellular Carcinoma
por: Chen, Weiqian, et al.
Publicado: (2020)

CircSOD2 induced epigenetic alteration drives hepatocellular carcinoma progression through activating JAK2/STAT3 signaling pathway
por: Zhao, Zhongwei, et al.
Publicado: (2020)

Targeting AGGF1 (angiogenic factor with G patch and FHA domains 1) for Blocking Neointimal Formation After Vascular Injury
por: Yao, Yufeng, et al.
Publicado: (2017)

High Expression of Angiogenic Factor with G-Patch and FHA Domain1 (AGGF1) Predicts Poor Prognosis in Gastric Cancer
por: Yao, Han-Hui, et al.
Publicado: (2017)

A role for the NPM1/PTPN14/YAP axis in mediating hypoxia-induced chemoresistance to sorafenib in hepatocellular carcinoma
por: Zhang, Dengke, et al.
Publicado: (2022)

The incidence and outcome of major complication following conventional TAE/TACE for hepatocellular carcinoma
por: Tu, Jianfei, et al.
Publicado: (2016)

Prediction of tumor response via a pretreatment MRI radiomics-based nomogram in HCC treated with TACE
por: Kong, Chunli, et al.
Publicado: (2021)

Sophoridine suppresses lenvatinib‐resistant hepatocellular carcinoma growth by inhibiting RAS/MEK/ERK axis via decreasing VEGFR2 expression
por: Zhao, Zhongwei, et al.
Publicado: (2020)

Efficacy and Safety of TACE Combined With Sorafenib Plus Immune Checkpoint Inhibitors for the Treatment of Intermediate and Advanced TACE-Refractory Hepatocellular Carcinoma: A Retrospective Study
por: Zheng, Liyun, et al.
Publicado: (2021)

Angiogenic factor AGGF1 blocks neointimal formation after vascular injury via interaction with integrin α7 on vascular smooth muscle cells
por: Yu, Yubing, et al.
Publicado: (2022)

LncRNA-SNHG6 promotes the progression of hepatocellular carcinoma by targeting miR-6509-5p and HIF1A
por: Fan, Xiaoxi, et al.
Publicado: (2021)

FGFR2-BICC1: A Subtype Of FGFR2 Oncogenic Fusion Variant In Cholangiocarcinoma And The Response To Sorafenib
por: Ying, Xihui, et al.
Publicado: (2019)

Integrated analysis reveals critical glycolytic regulators in hepatocellular carcinoma
por: Lu, Chenying, et al.
Publicado: (2020)

Correction to: Integrated analysis reveals critical glycolytic regulators in hepatocellular carcinoma
por: Lu, Chenying, et al.
Publicado: (2020)

Drug-eluting beads-transcatheter arterial chemoembolization with or without iodine-125 treatment is effective and tolerable in treating advanced non-small cell lung cancer patients: a pilot study
por: Zhao, Zhongwei, et al.
Publicado: (2020)

Triptonide Modulates MAPK Signaling Pathways and Exerts Anticancer Effects via ER Stress-Mediated Apoptosis Induction in Human Osteosarcoma Cells
por: Zheng, Liyun, et al.
Publicado: (2020)

Shikonin potentiates the effect of arsenic trioxide against human hepatocellular carcinoma in vitro and in vivo
por: Song, Jingjing, et al.
Publicado: (2016)

Identifying Apoptosis-Related Transcriptomic Aberrations and Revealing Clinical Relevance as Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma
por: Zhu, Jinyu, et al.
Publicado: (2021)

Radiomic Feature-Based Nomogram: A Novel Technique to Predict EGFR-Activating Mutations for EGFR Tyrosin Kinase Inhibitor Therapy
por: Weng, Qiaoyou, et al.
Publicado: (2021)

TACE responser NDRG1 acts as a guardian against ferroptosis to drive tumorgenesis and metastasis in HCC
por: Tang, Bufu, et al.
Publicado: (2023)

Piperlongumine, a Novel TrxR1 Inhibitor, Induces Apoptosis in Hepatocellular Carcinoma Cells by ROS-Mediated ER Stress
por: Zhang, Qianqian, et al.
Publicado: (2019)

Corrigendum: Piperlongumine, a Novel TrxR1 Inhibitor, Induces Apoptosis in Hepatocellular Carcinoma Cells by ROS-Mediated ER Stress
por: Zhang, Qianqian, et al.
Publicado: (2022)

High Cytoplasmic Expression of Krüppel-like Factor 4 Is an Independent Prognostic Factor of Better Survival in Hepatocellular Carcinoma
por: Hsu, Hui-Ting, et al.
Publicado: (2014)

The expression of AGGF1, FOXC2, and E-cadherin in esophageal carcinoma and their clinical significance
por: Ma, Li, et al.
Publicado: (2020)

Elevated expression of AGGF1 predicts poor prognosis and promotes the metastasis of colorectal cancer
por: Zhang, Xin, et al.
Publicado: (2019)

MicroRNA‐155‐5p suppresses PD‐L1 expression in lung adenocarcinoma
por: Huang, Jiansheng, et al.
Publicado: (2020)

Orthotopic hepatocellular carcinoma: molecular imaging-monitored intratumoral hyperthermia-enhanced direct oncolytic virotherapy
por: Song, Jingjing, et al.
Publicado: (2019)

Comprehensive Analysis Identified ASF1B as an Independent Prognostic Factor for HBV-Infected Hepatocellular Carcinoma
por: Wang, Xianmo, et al.
Publicado: (2022)

Vaccarin Regulates Diabetic Chronic Wound Healing through FOXP2/AGGF1 Pathways
por: Liu, Yixiao, et al.
Publicado: (2020)

Expression and Clinical Significance of the NCAPH, AGGF1, and FOXC2 Proteins in Serous Ovarian Cancer
por: Sun, Yingying, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rvkut0uvdu4mfd3e2jl5odln9o